Michael John Sumner - 30 Jun 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
30 Jun 2025
Net transactions value
$0
Form type
4
Filing time
01 Jul 2025, 16:08:06 UTC
Previous filing
21 May 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sumner Michael John Chief Medical Officer 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING /s/ Michael John Sumner 01 Jul 2025 0001936799

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +2,916 +20% 17,850 30 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -2,916 -100% $0.000000 0 30 Jun 2025 Common Stock 2,916 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.